Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.

If the trial is successful, the firm's complete estrogen receptor antagonist would complement its other biomarker-driven breast cancer assets.

If the trial is successful, the firm's complete estrogen receptor antagonist would complement its other biomarker-driven breast cancer assets.

Amgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of ...

As COVID-19 raged around the world five years ago, London community nurse Beverly Summers found herself on the frontline of ...

Norfolk entrepreneur Tait Pollack from Norwich has credited sleep for saving his life after recovering from a life-threating illness following ...

Meet Minnesota Orchestra’s Susie Park. Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ($560 million) investment in a vaccine manufacturing plant in northwest ...

AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from government. The investment, announced last year in the Tories' spring budget ...

A federal appeals court on Thursday ruled a nationwide ban on handgun sales to young adults is unconstitutional. A three-judge panel of the 5th U.S. Circuit Court of Appeals in New Orleans found a ...

Confirming the reversal on Friday, a spokesperson for AstraZeneca said: "Following discussions with the current Government, we are no longer pursuing our planned investment in Speke. "Several factors ...

AstraZeneca has pulled out of plans to build a new £450m facility in Liverpool. AstraZeneca, which produced one of the Covid-19 jabs, has an existing site on Renaissance Way, Speke and during the ...

The Danish pharmaceuticals giant said that its trial showed that people treated on the highest dose of 20mg of amycretin ... Danni Hewson and Dan Coatsworth said: "AstraZeneca’s shares stumbled in the ...